Tiny plastics in Kids' guts: could they worsen IBD?
NCT ID NCT07141238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether microplastics are found more often in children with inflammatory bowel disease (IBD) compared to healthy children. Researchers will collect samples of tissue, blood, urine, and stool from 40 children during routine endoscopy. No treatment is given—the goal is simply to measure and compare microplastic levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If it works, this could help understand whether microplastics play a role in inflammatory bowel disease in children.
- What could go wrong
- This is a small, early observational study that only measures microplastics, not tests a treatment. It may not find clear differences or prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pediatric patients undergoing endoscopy at a tertiary care academic hospital. The study includes children with confirmed inflammatory bowel disease and children undergoing endoscopy for other indications as controls.
- Ages
-
Up to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \<18 years * Undergoing clinically indicated gastrointestinal endoscopy * For IBD group: confirmed diagnosis of Crohn's disease or ulcerative colitis * For control group: no current or past diagnosis of IBD Exclusion Criteria: * Age 18 years or older * Lack of informed consent from legal guardian * Lack of written assent from the participant if age ≥13 years
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Crohn disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Medical University of Gdańsk, Department of Pediatrics, Gastroenterology, Allergolgy and Nutrition
RECRUITINGGdansk, 80-803, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune aging blood tests predict which older IBD patients thrive on advanced therapies?
- Triple-Pronged attack on gut inflammation put to the test
- Two biologics go head to head in ulcerative colitis
- Can a liquid diet calm Crohn's in kids?
- New drug ATTO-1091 put to the test for safety in ulcerative colitis
- Antiparasitic drug tested as new weapon against ulcerative colitis